#United States #New York #Levi & Korsinsky #Securities Fraud #Hims & Hers

Levi & Korsinsky Files Class Action for Hims & Hers Health Investors

On August 22, 2025, Levi & Korsinsky, LLP, a renowned law firm in securities litigation, announced that it has filed a class action lawsuit on behalf of investors in Hims & Hers Health, Inc. (NYSE: HIMS). This lawsuit aims to seek compensation for shareholders impacted by alleged securities fraud that occurred between April 29, 2025, and June 23, 2025. The firm's proactive approach informs affected investors about their rights and how to proceed if they seek to join the lawsuit.

Class Definition

The lawsuit is defined to address the grievances of Hims & Hers investors exposed to possible misinformation and fraudulent activities by the company's executives. According to the complaint, the defendants purportedly misled investors by making false statements and concealing critical information regarding the safety and efficacy of their products, particularly related to collaborations with major pharmaceutical companies.

Key Allegations

The filed complaint underscores serious accusations against Hims & Hers, involving claims that the company engaged in the deceptive promotion and selling of illegitimate versions of the medication Wegovy. This activity allegedly jeopardized patient safety and raised significant concerns about the company's partnership with Novo Nordisk. Consequently, statements made by the defendants regarding the company’s operations, growth prospects, and overall business health were deemed materially misleading and lacking a reasonable basis.

Investor Movements

The law firm urges anyone who suffered losses during the specified period to reach out by August 25, 2025, if they wish to request the Court to appoint them as lead plaintiff. Notably, participation in the suit does not necessitate acting as a lead plaintiff to be eligible for any potential financial recovery, which aligns with Levi & Korsinsky's commitment to lowering barriers for class members.

No Upfront Costs

A significant aspect of this class-action suit is that there are no out-of-pocket costs involved for class members. Investors can participate without paying upfront fees or incurring financial obligations. This approach exemplifies Levi & Korsinsky’s dedication to ensuring access to justice and providing legal support to those affected by corporate misconduct.

Firm's Reputation

Levi & Korsinsky has established a strong track record over the past two decades, recovering hundreds of millions of dollars for shareholders and emerging as a formidable entity in the realm of securities litigation. Their expertise and proven experience have earned them a spot on ISS Securities Class Action Services' Top 50 Report for seven consecutive years, highlighting their status among the leading security litigation firms in the United States.

Contact Details

For investors looking for assistance or wanting to learn more about the class action, Levi & Korsinsky has made available various points of contact, including reaching out to Joseph E. Levi, Esq., via email or telephone. Investors can also utilize the dedicated platform provided by the law firm to submit their information and express their willingness to join the case.

Conclusion

The allegations against Hims & Hers Health, Inc. pose serious concerns for investors and underlines the importance of due diligence in assessing corporate communications and partnerships. Through this class-action lawsuit, Levi & Korsinsky not only seeks justice but also enhances the accountability of corporations to their shareholders. As more investors become aware of their rights and the potential for recovery, this case could foster a greater understanding of the responsibilities companies hold regarding transparent communication and ethical practices.